Yunfeng Shen

6PUBLICATIONS
4CO-AUTHORS
Genetically modified animalsGene and molecular therapyPharmacogenomicsCancer geneticsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 22, 2025
Empagliflozin Downregulates AMP-Activated Protein Kinaseα O-GlcNAcylation to Ameliorate Hepatic Steatosis.

Yicheng Zhou, MinXuan Xu, Piaojian Yu

|Jun 13, 2024
Wearable monitoring device based on an internet management platform improves metabolic parameters in type 2 diabetes patients: a prospective pilot study.

Ping Peng, Yunfeng Shen, Haixia Xiong

|Nov 08, 2023
Glucagon-Like Peptide-1 Receptor Agonist and Risk of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.

Xiaojuan Jiao, Ping Peng, Qin Zhang

|Nov 26, 2022
O-GlycNacylation Remission Retards the Progression of Non-Alcoholic Fatty Liver Disease.

Yicheng Zhou, Zhangwang Li, Minxuan Xu

|Aug 19, 2021
Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression.

Lidan Cheng, Peng Yu, Fangfang Li

|Jun 26, 2019
Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway.

Peng Yu, Xi Xu, Jing Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Yicheng Zhou

1 joint publications

Zhangwang Li

1 joint publications

Deju Zhang

1 joint publications

Jitao Ling